Pilot Trial of the Move Healthier Group

April 23, 2026 updated by: Elizabeth.W.Lampe, Dartmouth-Hitchcock Medical Center
The researchers are developing a new exercise-focused group and are interested in studying whether this group helps people increase their exercise without increasing risk for disordered eating behaviors.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

Individuals seeking weight loss are often encouraged to increase their exercise engagement as a health-promoting behavior. However, exercise engagement is often connected directly to caloric intake within weight loss interventions, so it is likely that individuals seeking weight loss are engaging in some level of compensatory exercise even in the absence of other disordered eating symptoms. Compensatory exercise is defined as exercising to "offset" or "make up for" calories consumed with the intent of controlling one's body weight or shape. The researchers are developing a new group to promote healthy exercise and are interested in studying whether this group helps people increase their exercise without increasing risk for compensatory exercise or other disordered eating behaviors.

Study Type

Interventional

Enrollment (Estimated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Hampshire
      • Lebanon, New Hampshire, United States, 03766
        • Dartmouth-Hitchcock Clinics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Seen for weight loss treatment at DHMC Weight Center within the past year
  • Speak, read, & write English fluently
  • Age 18 or older
  • Appropriate for group visits (as assessed by referring provider)

Exclusion Criteria:

  • Meets DSM-5 criteria for an eating disorder based on behavior frequencies reported on baseline EDE-Q
  • Report contraindications for unsupervised physical activity on the PAR-Q, or have not been medically cleared by an MD for participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Move Healthier Group Intervention Arm
This group-based intervention aims to promote healthy exercise without increasing risk for compensatory exercise or other disordered eating behaviors. Participants will attend 12 weekly 90-minute group intervention sessions via telehealth software.
The intervention aims to increase exercise using cognitive and behavioral skills integrated across several treatment manuals including the Physical Activity Cognitively Enhanced (PACE) intervention for healthy exercise promotion in eating disorders, acceptance-based and standard behavioral weight loss manuals, and affect-guided exercise prescriptions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective physical activity
Time Frame: From enrollment to the end of treatment at 12 weeks
Objective physical activity will be measures as the total number of minutes per week of physical activity measured via Fitbit device worn during waking hours. The Fitbit data will yield a total count of the number of minutes of moderate-to-vigorous physical activity for each week during the intervention period, with higher counts indicating greater levels of activity.
From enrollment to the end of treatment at 12 weeks
Self-reported physical activity
Time Frame: From enrollment to the end of treatment at 12 weeks
Participants will also complete self-report measures of physical activity, including the International Physical Activity Questionnaire (IPAQ) and IPAQ-short form at group sessions and study assessments. The IPAQ asks patients to report on their total physical activity engagement over the past 7 days by light, moderate, and vigorous activity categories. The IPAQ yields a total count of the number of minutes of moderate-to-vigorous physical activity over the past week, with higher minutes indicating more activity.
From enrollment to the end of treatment at 12 weeks
Eating disorder symptoms
Time Frame: Baseline and post-intervention (week 12)
ED symptoms will be assessed via the Eating Disorder Examination Questionnaire (EDE-Q 6.0), which asks about ED symptoms over the past month (28 days). Compensatory exercise engagement will be assessed via an item asking, "Over the past 28 days, how many times have you exercised to "make up for" a binge-eating episode, and compulsive exercise will be assessed using the item "...how many times have you felt driven/compelled to exercise?" EDE-Q items are averages to calculate a total score ranging from 0-6, with higher scores indicating higher levels of eating pathology.
Baseline and post-intervention (week 12)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight bias internalization
Time Frame: baseline and post-intervention (week 12)
Internalized weight stigma will be measured using the Weight Bias Internalization Scale (WBIS). The WBIS comprises 11 items measuring self-directed weight bias and has shown excellent convergent and divergent validity within the population of interest. The WBIS items are averaged to yield a total score ranging from 1-7, with higher scores reflecting higher internalized weight bias.
baseline and post-intervention (week 12)
intervention acceptability
Time Frame: post-intervention (week 12)
Participants will complete qualitative interviews at post-treatment to provide feedback on group format, acceptability, utility, etc. Qualitative analysis of these interview transcripts will elucidate themes related to group acceptability.
post-intervention (week 12)
intervention feasibility
Time Frame: post-intervention (week 12)
Feasibility will be measured via group attendance rates across the 12 sessions.
post-intervention (week 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jessica Salwen-Deremer, PhD, Dartmouth Health
  • Principal Investigator: Elizabeth Lampe, PhD, Dartmouth Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 16, 2026

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

August 30, 2026

Study Registration Dates

First Submitted

January 13, 2026

First Submitted That Met QC Criteria

February 5, 2026

First Posted (Actual)

February 12, 2026

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 23, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD may be shared to facilitate future research study recruitment and/or to answer future research questions. There is no plan to share IPD at this time.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Move Healthier Intervention

Subscribe